Published in

American Association for the Advancement of Science, Science Translational Medicine, 491(11), 2019

DOI: 10.1126/scitranslmed.aau1167

Links

Tools

Export citation

Search in Google Scholar

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Targeting oxidative phosphorylation overcomes ibrutinib resistance in mantle cell lymphoma.